First Trust Direct Indexing’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,162
Closed -$19.6M 518
2024
Q3
$19.6M Buy
22,162
+1,317
+6% +$1.18M 1.05% 10
2024
Q2
$18.9M Buy
20,845
+3,554
+21% +$2.84M 1.17% 9
2024
Q1
$13.5M Buy
17,291
+1,917
+12% +$1.36M 1% 10
2023
Q4
$8.96M Buy
15,374
+2,433
+19% +$1.42M 0.8% 13
2023
Q3
$6.95M Buy
12,941
+35
+0.3% +$18K 0.79% 12
2023
Q2
$6.05M Buy
12,906
+771
+6% +$323K 0.67% 19
2023
Q1
$4.17M Buy
12,135
+337
+3% +$114K 0.49% 29
2022
Q4
$4.32M Sell
11,798
-264
-2% -$93.6K 0.57% 22
2022
Q3
$3.9M Buy
12,062
+66
+0.6% +$20.9K 0.57% 24
2022
Q2
$3.89M Buy
11,996
+661
+6% +$198K 0.54% 29
2022
Q1
$3.25M Buy
11,335
+982
+9% +$253K 0.39% 42
2021
Q4
$2.86M Buy
10,353
+68
+0.7% +$17.2K 0.37% 46
2021
Q3
$2.38M Buy
10,285
+304
+3% +$75K 0.34% 51
2021
Q2
$2.29M Buy
9,981
+3,113
+45% +$625K 0.34% 53
2021
Q1
$1.28M Buy
6,868
+437
+7% +$85.5K 0.34% 67
2020
Q4
$1.09M Buy
+6,431
New +$960K 0.29% 65

Other funds holding LLY

First Trust Direct Indexing's LLY Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 22,162 shares — an estimated $19.6M sold.

First Trust Direct Indexing first reported a position in LLY in Q4 2020 and held it in 16 quarters. The position peaked at $19.6M in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 22,162 Eli Lilly shares in Q4 2024, an estimated $19.6M.
  • First Trust Direct Indexing first reported a position in Eli Lilly in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Eli Lilly position peaked at $19.6M in Q3 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.